Ray Past Earnings Performance
Past criteria checks 0/6
Ray's earnings have been declining at an average annual rate of -50.4%, while the Medical Equipment industry saw earnings growing at 16.7% annually. Revenues have been growing at an average rate of 20.9% per year.
Key information
-50.4%
Earnings growth rate
-52.5%
EPS growth rate
Medical Equipment Industry Growth | 22.7% |
Revenue growth rate | 20.9% |
Return on equity | -22.6% |
Net Margin | -17.5% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Ray Co., Ltd. (KOSDAQ:228670) Not Doing Enough For Some Investors As Its Shares Slump 32%
Aug 05Ray (KOSDAQ:228670) Has A Somewhat Strained Balance Sheet
Jul 24Market Still Lacking Some Conviction On Ray Co., Ltd. (KOSDAQ:228670)
May 25The Returns On Capital At Ray (KOSDAQ:228670) Don't Inspire Confidence
Mar 14Is Ray (KOSDAQ:228670) Using Too Much Debt?
Mar 16What Type Of Shareholders Make Up Ray Co., Ltd.'s (KOSDAQ:228670) Share Registry?
Feb 21With A Return On Equity Of 13%, Has Ray Co., Ltd.'s (KOSDAQ:228670) Management Done Well?
Feb 02We Wouldn't Rely On Ray's (KOSDAQ:228670) Statutory Earnings As A Guide
Jan 14If You Had Bought Ray (KOSDAQ:228670) Shares A Year Ago You'd Have Earned 11% Returns
Dec 27Here's Why Ray (KOSDAQ:228670) Can Manage Its Debt Responsibly
Dec 08Has Ray (KOSDAQ:228670) Got What It Takes To Become A Multi-Bagger?
Nov 19Revenue & Expenses Breakdown
How Ray makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 128,613 | -22,552 | 63,037 | 7,091 |
31 Mar 24 | 143,226 | -4,452 | 50,076 | 7,074 |
31 Dec 23 | 145,882 | -2,146 | 50,142 | 6,986 |
30 Sep 23 | 145,143 | 7,518 | 45,846 | 7,054 |
30 Jun 23 | 139,591 | 6,462 | 44,661 | 6,863 |
31 Mar 23 | 131,396 | 5,346 | 39,536 | 6,336 |
31 Dec 22 | 128,998 | 7,957 | 34,653 | 6,163 |
30 Sep 22 | 108,356 | -5,628 | 30,896 | 5,979 |
30 Jun 22 | 100,533 | -2,984 | 26,102 | 5,829 |
31 Mar 22 | 93,026 | 1,241 | 22,277 | 5,481 |
31 Dec 21 | 90,336 | -13 | 20,641 | 5,063 |
30 Sep 21 | 84,681 | 12,727 | 17,410 | 4,667 |
30 Jun 21 | 73,676 | 9,988 | 16,847 | 4,315 |
31 Mar 21 | 57,803 | 4,645 | 16,457 | 4,411 |
31 Dec 20 | 55,205 | 7,904 | 15,409 | 4,180 |
30 Sep 20 | 57,260 | 7,979 | 16,256 | 3,858 |
30 Jun 20 | 61,781 | 8,891 | 16,831 | 3,484 |
31 Mar 20 | 71,986 | 12,340 | 16,742 | 3,178 |
31 Dec 19 | 73,109 | 11,555 | 16,785 | 3,220 |
30 Sep 19 | 69,512 | 10,843 | 16,118 | 3,207 |
31 Mar 19 | 57,594 | 7,019 | 14,141 | 3,107 |
31 Dec 18 | 51,534 | 5,251 | 13,365 | 2,843 |
31 Dec 17 | 32,929 | 1,154 | 10,749 | 2,014 |
31 Dec 16 | 26,499 | 1,713 | 7,364 | 1,983 |
31 Dec 15 | 20,528 | 207 | 7,183 | 1,297 |
Quality Earnings: A228670 is currently unprofitable.
Growing Profit Margin: A228670 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A228670 is unprofitable, and losses have increased over the past 5 years at a rate of 50.4% per year.
Accelerating Growth: Unable to compare A228670's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A228670 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (5.3%).
Return on Equity
High ROE: A228670 has a negative Return on Equity (-22.58%), as it is currently unprofitable.